Dr. Mell on Risk Stratification for Head and Neck Cancer

Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses risk stratification for patients with head and neck cancer.

According to Mell, it is important to understand which patients are likely to benefit from more or less intensive therapies.

Researchers are undergoing efforts to make staging patients more mathematical, explains Mell. Staging is used to get a sense for how extensive the cancer is and which treatment option will be most beneficial.